StockData

Commercial Metals vs Carpenter Technology

CMC and CRS side by side, both in steel works, blast furnaces, and rolling and finishing mills. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CMC and CRS compare

Carpenter Technology is the larger company, worth 2.0 times as much as Commercial Metals ($14.0B against $7.1B).

On earnings, Commercial Metals is cheaper: it trades at 10.9× trailing earnings, against 26.9× for Carpenter Technology.

Commercial Metals grew revenue faster over the last twelve months (20.5% versus 8.6% for Carpenter Technology).

Carpenter Technology keeps more of each dollar of sales as profit, with a net margin of 17.0% compared with 7.0% at Commercial Metals.

Both pay dividends: Commercial Metals yields 0.91% and Carpenter Technology 0.21%.

Carpenter Technology scores higher on the StockData Score (21 against 15 for Commercial Metals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCMCCRS
Size and price
Market cap$7.1B$14.0B
Share price$63.98$283.08
Change, 1 year4.8%−12.5%
Change, 5 years89.4%764%
Beta (5Y)1.151.37
Employees14K4,500
StockData Score
Total score1521 (better)
Valuation score33
Growth score34 (better)
Performance score34 (better)
Health score26 (better)
Dividend score44
Valuation
P/E10.9× (better)26.9×
P/S0.8× (better)4.5×
P/B1.5× (better)6.3×
EV/EBITDA8.7× (better)16.9×
P/FCF14.8× (better)38.7×
PEG–0.25
FCF yield6.8% (better)2.6%
Fair value$76.98$301.35
Margin of safety16.9% (better)6.1%
Growth
Revenue growth (TTM)20.5% (better)8.6%
Revenue growth, 5Y average6.9%16.2% (better)
Net income growth (TTM)675% (better)40.9%
EPS growth (TTM)692% (better)41.8%
EPS growth, 5Y average11.6%–
Profitability
Gross margin18.6%30.6% (better)
Operating margin–22.5%
Net margin7.0%17.0% (better)
FCF margin5.1%11.6% (better)
Return on equity14.8%25.8% (better)
Return on invested capital–23.7%
Financial health
Debt / equity0.720.31 (better)
Net debt / EBITDA2.350.35 (better)
Interest coverage–18.6×
Current ratio2.343.81 (better)
Altman Z-score2.637.90 (better)
Piotroski F-score79 (better)
Dividends and buybacks
Dividend yield0.91% (better)0.21%
Payout ratio12.8%7.6%
Years of dividend growth5 (better)0
Dividend growth, 5Y average9.6% (better)0.00%
Buyback yield1.5% (better)1.3%
Shareholder yield2.4% (better)1.5%
Ownership
Held by institutions93.8%94.2%
Held by insiders0.84%2.6%
Insider net buying, 12 months−$1.2M (better)−$94.6M
Superinvestors holding–2
Short interest, % of float5.8%3.0%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.